1. Market Research
  2. > Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review

Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Celesio AG (Celesio) is an international trading company. It provides an array of services for pharmaceutical and healthcare markets in Europe. The company operates a large network of pharmacies, which provides drugs and health related services to patients. Apart from, prescription and non-prescription pharmaceuticals, it provides blood pressure, cholesterol, and diabetes testing services. The company also undertakes pharmacy and laboratory equipment business; and property development for pharmacies. The company operates its business through two divisions, namely, Consumer Solutions and Pharmacy Solutions. Celesio is a subsidiary of McKesson Corporation and is headquartered in Stuttgart, Germany.

The company seeks to drive innovation and efficiency along the supply chain to improve the quality of services for patients and consumers. It also plans to undertake focused expansion initiatives.

Celesio AG Key Recent Developments

Oct 14, 2013: Markus Georgi appointed new Director of Celesio Investor Relations
Aug 14, 2013: Celesio: H1 performance satisfactory overall, in line with expectations
Jul 19, 2013: New Managing Director at pharmaceutical wholesaler Panpharma
Jul 03, 2013: Changes in the Management Board of Celesio
May 14, 2013: Celesio Reports Revenue Of €5.4 Billion In Q1 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review
Table of Contents

Table of Contents 2

List of Tables

List of Figures
Section 1 - About the Company 6
Celesio AG - Key Facts 6
Celesio AG - Key Employees 7
Celesio AG - Key Employee Biographies 8
Celesio AG - Major Products and Services 9
Celesio AG - History 10
Celesio AG - Company Statement 13
Celesio AG - Locations And Subsidiaries 14
Head Office 14
Other Locations and Subsidiaries 14
Joint Venture 15
Section 2 - Company Analysis 16
Celesio AG - Business Description 16
Celesio AG - SWOT Analysis 17
SWOT Analysis - Overview 17
Celesio AG - Strengths 17
Strength - Awards and Recognitions 17
Strength - Extensive Pharmacy Chain 17
Strength - Increasing Topline Performance 17
Celesio AG - Weaknesses 18
Weakness - Substantial Increase in Non-Cash Components of Current Assets 18
Weakness - Declining Profitability 18
Celesio AG - Opportunities 19
Opportunity - Business Combination 19
Opportunity - Growth Prospects: E-Commerce 19
Opportunity - Market Potential: Healthcare and Pharmaceutical 19
Opportunity - Expansion through Acquisitions 19
Celesio AG - Threats 20
Threat - Competitive Landscape 20
Threat - Increase in Counterfeit Products 20
Threat - Regulated Industry 20
Celesio AG - Key Competitors 21
Section 3 - Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Celesio AG, Recent Deals Summary 28
Section 4 - Company's Recent Developments 29
Mar 14, 2014: John H. Hammergren is the new Chairman of the Supervisory Board of Celesio AG 29
Section 5 - Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables

Celesio AG, Key Facts 6
Celesio AG, Key Employees 7
Celesio AG, Key Employee Biographies 8
Celesio AG, Major Products and Services 9
Celesio AG, History 10
Celesio AG, Subsidiaries 14
Celesio AG, Joint Venture 15
Celesio AG, Key Competitors 21
Celesio AG, Ratios based on current share price 22
Celesio AG, Annual Ratios 23
Celesio AG, Interim Ratios 26
Celesio AG, Recent Deals Summary 28
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List of Figures

Celesio AG, Performance Chart (2010 - 2014) 25
Celesio AG, Ratio Charts 27

Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.